Protection against experimental infection with group B streptococcus by immunization with a bivalent protein vaccine
- 21 January 1999
- Vol. 17 (5) , 454-458
- https://doi.org/10.1016/s0264-410x(98)00218-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Adjuvants—a classification and review of their modes of actionPublished by Elsevier ,1998
- Highly Conserved Neisseria meningitidis Surface Protein Confers Protection against Experimental InfectionThe Journal of Experimental Medicine, 1997
- Identification of a Family of Streptococcal Surface Proteins with Extremely Repetitive StructureJournal of Biological Chemistry, 1996
- PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in miceVaccine, 1996
- Structural and Immunochemical Characterization of the Type VIII Group B Streptococcus Capsular PolysaccharideJournal of Biological Chemistry, 1996
- Invasive Group B Streptococcal Disease: The Emergence of Serotype VThe Journal of Infectious Diseases, 1996
- Comparison of Prevention Strategies for Neonatal Group B Streptococcal InfectionJAMA, 1993
- A Population-Based Assessment of Invasive Disease Due to Group B Streptococcus in Nonpregnant AdultsNew England Journal of Medicine, 1993
- Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections.The Journal of Experimental Medicine, 1993
- Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci.Proceedings of the National Academy of Sciences, 1992